- Motley Fool•1 hour ago
Cancer drug developers are reporting significant advances that could revolutionize cancer treatment.
- Motley Fool•2 days ago
Fitbit, Ariad Pharmaceuticals, and Trex Company may all be poised to deliver significant returns to investors.
- Investor's Business Daily•3 days ago
European, Japanese or specialty pharma could look to acquire Ariad as it rapidly closes in on approval of a lung cancer drug, RBC says.
ARIA : Summary for ARIAD Pharmaceuticals, Inc. - Yahoo Finance
ARIAD Pharmaceuticals, Inc. (ARIA)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||12.65 x 200|
|Ask||12.93 x 4000|
|Day's Range||12.67 - 13.33|
|52 Week Range||4.37 - 14.42|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-72.87|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|